Lung Function Tests Market Research Report - Global Forecast till 2027

Lung Function Tests Market Information: By Type (Spirometry, Bronchial Provocation Test), Indication (Asthma, Chronic Bronchitis, Respiratory Infections, COPD, Cystic Fibrosis), Devices (Spirometer, Oscillometer), End-User - Global Forecast Till 2027

ID: MRFR/LS/3401-HCR | | Region : Global

Market Synopsis of the Global Lung Function Tests Market


Lung function tests, also known as pulmonary function test is used for the diagnosis of lung disorders such as asthma, respiratory infections, chronic obstructive pulmonary disease (COPD), and others. These group of tests also determine the functioning of the lungs, and the ability of a person to breath. They are also a part of tests for routine examination by the healthcare provider. The healthcare provider may recommend lung function tests to diagnose the suspected lung disease, plan the treatment, and decide whether to continue the ongoing treatment or change it and even to stop the treatment if required. Therefore, lung function test plays a vital role in the diagnosis of various respiratory diseases, and lung disorders.


Rising prevalence of lung diseases such as asthma, COPD, and others, availability of lung function test devices, and increasing demand for lung function tests are important factors accelerating the growth of the market. Technological advancements in lung testing and the growing geriatric population are also influencing the market growth. Changing lifestyle, and smoking addiction are leading to a number of lung problems such as lung cancer, which is further driving the growth of the market.


The global lung function tests market is expected to grow at a CAGR of 5.7% during the forecast period.


Regional Analysis of the Global Lung Function Tests Market


America is the leading market for lung function tests owing to the rising prevalence of various types of allergies in the U.S. According to the American College of Allergy Asthma and Immunology, allergic asthma, food allergy, and eczema are the most common types of allergies in the U.S. It further stated that 1 in every 12 people is suffering from allergic rhinitis in the U.S.


Europe is the second-largest market for lung function tests. In Europe, the prevalence of allergic conditions is found to be increasing rapidly. Therefore, the rising prevalence of allergic conditions such as asthma, food allergy, and anaphylaxis is increasing the demand for diagnostic services. Furthermore, rising awareness regarding available treatments and skin testing are fueling the growth of the market. As per the European Academy of Allergy and Clinical Immunology, 150 million EU citizens have the chronic allergic diseases. Additionally, 100 million Europeans have allergic rhinitis.


The Asia Pacific market is expected to grow at the fastest pace and is driven by the high prevalence of asthma, rising geriatric population, and increasing environmental population. Weak immune systems and high prevalence of asthma are major risk factors for allergies among the elderly population. Additionally, the prevalence of COPD is also on the rise, which is boosting the growth of the market.


The Middle East & Africa also show a steady rise in the market owing to the high prevalence of chronic respiratory diseases like asthma, and improving healthcare infrastructure. Increasing demand for diagnostic services also influences the market growth in the Middle East & African countries.


FIGURE 1: Global Lung Function Tests Market by Region, 2016 (%) Lung Function Tests Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Segments 


The global lung function tests market is segmented on the basis of type, indication, devices, and end-user.


On the basis of the type, the market is segmented into spirometry, gas diffusion test, body plethysmograph, bronchial provocation test, and others.


On the basis of the indication, the market is segmented into asthma, chronic bronchitis, respiratory infections, chronic obstructive pulmonary disease, cystic fibrosis, pneumonia, lung cancer, and others.


On the basis of the devices, the market is segmented into a spirometer, breath CO monitor, oscillometer, ergospirometer, dose controlled drug nebulizer, and others.


On the basis of the end-user, the market is segmented into hospitals, clinics, diagnostic centers, and others.


Research Methodology Research Methodology


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Key Players in the Global Lung Function Tests Market


Some of the Key Players in this market are CareFusion Corporation (U.S.), MGC Diagnostic Corporation (U.S.), General Electric Company (U.S.), Perkin Elmer (U.S), Carestream Health, Inc. (U.S.), COSMED srl (Italy), NIHON KOHDEN CORPORATION (Japan), and others.


Intended Audience



  • Drug Manufacturers

  • Drug Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Lung Function Tests Market, by Type

6.1 Introduction

6.2 Spirometry

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Gas Diffusion Test

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Body Plethysmography

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Bronchial Provocation Test

6.5.1 Market Estimates & Forecast, 2020-2027

7. Global Lung Function Tests Market, by Indication

7.1 Introduction

7.2 Asthma

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Chronic Bronchitis

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Respiratory Infections

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Chronic Obstructive Pulmonary Disease

7.5.1 Market Estimates & Forecast, 2020-2027

7.6 Cystic Fibrosis

7.6.1 Market Estimates & Forecast, 2020-2027

7.7 Pneumonia

7.7.1 Market Estimates & Forecast, 2020-2027

8. Global Lung Function Tests Market, by Device

8.1 Introduction

8.2 Spirometer

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Breath CO MONITOR

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Oscillometer

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Ergospirometer

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Dose Controlled Drug Nebuliser

8.6.1 Market Estimates & Forecast, 2020-2027

9. Global Lung Function Tests Market, by End User

9.1 Introduction

9.2 Hospitals

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Clinics

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Diagnostic Centers

9.4.1 Market Estimates & Forecast, 2020-2027

10. Global Lung Function Tests Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 U.K

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 CAREFUSION CORPORATION

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 MGC Diagnostic Corporation

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 GENERAL ELECTRIC COMPANY

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Perkin Elmer

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Carestream Health, Inc.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 COSMED srl

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 NIHON KOHDEN CORPORATION

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Diagnostic Tests Industry

14 Appendix

LIST OF TABLES

Table 1 Lung Function Tests Industry Synopsis, 2020-2027

Table 2 Global Lung Function Tests Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Lung Function Tests Market by Region, 2020-2027, (USD Million)

Table 4 Global Lung Function Tests Market by Types, 2020-2027, (USD Million)

Table 5 Global Lung Function Tests Market by Indication, 2020-2027, (USD Million)

Table 6 Global Lung Function Tests Market by Devices, 2020-2027, (USD Million)

Table 7 Global Lung Function Tests Market by End Users, 2020-2027, (USD Million)

Table 8 North America Lung Function Tests Market by Types, 2020-2027, (USD Million)

Table 9 North America Lung Function Tests Market by Indication, 2020-2027, (USD Million)

Table 10 North America Lung Function Tests Market by Devices, 2020-2027, (USD Million)

Table 11 North America Lung Function Tests Market by End Users, 2020-2027, (USD Million)

Table 12 US Lung Function Tests Market by Types, 2020-2027, (USD Million)

Table 13 US Lung Function Tests Market by Indication, 2020-2027, (USD Million)

Table 14 US Lung Function Tests Market by Devices, 2020-2027, (USD Million)

Table 15 US Lung Function Tests Market by End Users, 2020-2027, (USD Million)

Table 16 Canada Lung Function Tests Market by Types, 2020-2027, (USD Million)

Table 17 Canada Lung Function Tests Market by Indication, 2020-2027, (USD Million)

Table 18 Canada Lung Function Tests Market by Devices, 2020-2027, (USD Million)

Table 19 Canada Lung Function Tests Market by End Users, 2020-2027, (USD Million)

Table 20 South America Lung Function Tests Market by Types, 2020-2027, (USD Million)

Table 21 South America Lung Function Tests Market by Indication, 2020-2027, (USD Million)

Table 22 South America Lung Function Tests Market by Devices, 2020-2027, (USD Million)

Table 23 South America Lung Function Tests Market by End Users, 2020-2027, (USD Million)

Table 24 Europe Lung Function Tests Market by Types, 2020-2027, (USD Million)

Table 25 Europe Lung Function Tests Market by Indication, 2020-2027, (USD Million)

Table 26 Europe Lung Function Tests Market by Devices, 2020-2027, (USD Million)

Table 27 Europe Lung Function Tests Market by End Users, 2020-2027, (USD Million)

Table 28 Western Europe Lung Function Tests Market by Types, 2020-2027, (USD Million)

Table 29 Western Europe Lung Function Tests Market by Indication, 2020-2027, (USD Million)

Table 30 Western Europe Lung Function Tests Market by Devices, 2020-2027, (USD Million)

Table 31 Western Europe Lung Function Tests Market by End Users, 2020-2027, (USD Million)

Table 32 Eastern Europe Lung Function Tests Market by Types, 2020-2027, (USD Million)

Table 33 Eastern Europe Lung Function Tests Market by Indication, 2020-2027, (USD Million)

Table 34 Eastern Europe Lung Function Tests Market by Devices, 2020-2027, (USD Million)

Table 35 Eastern Europe Lung Function Tests Market by End Users, 2020-2027, (USD Million)

Table 36 Asia Pacific Lung Function Tests Market by Types, 2020-2027, (USD Million)

Table 37 Asia Pacific Lung Function Tests Market by Indication, 2020-2027, (USD Million)

Table 38 Asia Pacific Lung Function Tests Market by Devices, 2020-2027, (USD Million)

Table 39 Asia Pacific Lung Function Tests Market by End Users, 2020-2027, (USD Million)

Table 40 Middle East & Africa Lung Function Tests Market by Types, 2020-2027, (USD Million)

Table 41 Middle East & Africa Lung Function Tests Market by Indication, 2020-2027, (USD Million)

Table 42 Middle East & Africa Lung Function Tests Market by Devices, 2020-2027, (USD Million)

Table 43 Middle East & Africa Lung Function Tests Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Lung Function Tests Market

Figure 3 Segmentation Market Dynamics for Lung Function Tests Market

Figure 4 Global Lung Function Tests Market Share, by Indication 2020

Figure 5 Global Lung Function Tests Market Share, by Devices 2020

Figure 6 Global Lung Function Tests Market Share, by End Users, 2020

Figure 7 Global Lung Function Tests Market Share, by Region, 2020

Figure 8 North America Lung Function Tests Market Share, by Country, 2020

Figure 9 Europe Lung Function Tests Market Share, by Country, 2020

Figure 10 Asia Pacific Lung Function Tests Market Share, by Country, 2020

Figure 11 Middle East & Africa Lung Function Tests Market Share, by Country, 2020

Figure 12 Global Lung Function Tests Market: Company Share Analysis, 2020 (%)

Figure 13 CAREFUSION CORPORATION: Key Financials

Figure 14 CAREFUSION CORPORATION: Segmental Revenue

Figure 16 CAREFUSION CORPORATION: Geographical Revenue

Figure 17 MGC Diagnostic Corporation: Key Financials

Figure 18 MGC Diagnostic Corporation: Segmental Revenue

Figure 19 MGC Diagnostic Corporation: Geographical Revenue

Figure 20 GENERAL ELECTRIC COMPANY: Key Financials

Figure 21 GENERAL ELECTRIC COMPANY: Segmental Revenue

Figure 22 GENERAL ELECTRIC COMPANY: Geographical Revenue

Figure 23 Perkin Elmer: Key Financials

Figure 24 Perkin Elmer: Segmental Revenue

Figure 25 Perkin Elmer: Geographical Revenue

Figure 26 COSMED srl: Key Financials

Figure 27 COSMED srl: Segmental Revenue

Figure 28 COSMED srl: Geographical Revenue

Figure 29 Carestream Health, Inc.: Key Financials

Figure 30 Carestream Health, Inc.: Segmental Revenue

Figure 31 Carestream Health, Inc.: Geographical Revenue

Figure 32 Pfizer Inc: Key Financials

Figure 33 Pfizer Inc: Segmental Revenue

Figure 34 Pfizer Inc: Geographical Revenue